Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
There are supply chain opportunities for hospitals and health systems to streamline inefficient workflows, including the removal of excessive labor spent on unnecessary and redundant tasks. To capitalize on this upside, consider automating time-consuming supply chain tasks to empower hospital…
Ruth Damron, Cardinal Health
Grand Prairie, Texas-based Bestherbs Coffee voluntarily recalled its New of Kopi Jantan Tradisional Natural Herbs Coffee July 13 after a Food and Drug Administration laboratory analysis detected an undeclared active drug ingredient.
The Food and Drug Administration on July 17 approved Puma Biotechnology's drug Nerlynx to treat early-stage breast cancer patients with a HER2 genetic mutation.
Supply chain key performance indicator dashboards must provide more information than just current business metrics, according to Sujit Singh, COO of the supply chain software solutions provider Arkieva.
Eight Alzheimer's drugs in phase II clinical trials and 27 Alzheimer's drugs in phase III clinical trials are on track to launch within the next five years, according to an analysis conducted by ResearchersAgainstAlzheimer's, a global network of more than…
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., will develop a technology innovation center in Austin, Texas, following Gov. Greg Abbott's commitment to provide the company with a $6 million grant from the Texas Enterprise Fund, reports…
The following drug companies made headlines this past week.
The Dublin-based drugmaker Shire is lobbying against several provisions in the Republican's healthcare reform plan, according to CEO Flemming Ornskov, MD.
Two former drug executives at a Tinton Falls, N.J.-based cancer drug distribution company on Friday pled guilty to selling medical supplies contaminated with mold, reports New York Daily News.
The Food and Drug Administration user fee reauthorization bill, which House representatives passed Wednesday, contains a measure that would triple the amount of time device companies have to report product issues, reports Star Tribune.